Can a simple eye test diagnose Multiple Sclerosis (MS)? “Absolutely,” says Dr. Diana Driscoll, a board-certified optometrist and leading expert in the research and treatment of invisible illnesses. To know more, watch Dr. Driscoll’s interview with the...
Press
Dr. Driscoll and her work are featured across a range of media formats and news outlets. Check-in regularly to catch Dr. Driscoll’s latest press releases, interviews, appearances, and news articles.
POTS Care® Provides Help for Long-COVID Patients
DALLAS, TEXAS, UNITED STATES, June 29, 2021 /EINPresswire.com/ -- Dr. Diana Driscoll, clinical director of POTS Care, has introduced a treatment program for COVID-19 patients who continue to suffer with lingering symptoms of illness long after their viral...
Diana Driscoll’s Press Kit
Diana Driscoll’s CV
See Dr. Driscoll’s licenses, qualifications, publications, research, and awards. View CV
Genetic Disease Investigators, LLC Awarded Patent For Dry Eye Treatment
Genetic Disease Investigators, LLC announced the receipt of its second patent, a new and innovative treatment for dry eye. The research company's formula works through the body’s autonomic nervous system, stimulating the release and production of specific...
Genetic Disease Investigators, LLC Awarded Patent For Dysautonomia Treatment
The Canadian Intellectual Property Office issued a patent to Genetic Disease Investigators, LLC for its new method of treating organ dysfunction by stimulating the vagus nerve. Read Full Press Release
Invisible Illnesses: Underlying Medical Problems
In this article for Disabled World, invisible illness expert Dr. Diana Driscoll discusses the diagnosis and treatment of Postural Orthostatic Tachycardia Syndrome (POTS), Chronic Fatigue Syndrome (ME/CFS), vagus nerve disorders, and Ehlers-Danlos syndrome (EDS). Read...
Interview with Startup.Info
Diana Driscoll, Optometrist and CEO of POTS Care, talks with Startup.Info about how she handled the difficult changes forced by the pandemic. She also discusses the connection between COVID-19 Long-Haulers and POTS. Read the full interview at Startup.Info.